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The aim of the present study was to investigate the protective role of methanolic leaf extract of Ocimum basilicum L. against
benzene-induced hematotoxicity in Swiss albino mice. GC analysis and subacute toxicity level of the extract were tested. Mice were
randomly divided into three groups among which II and III were exposed to benzene vapour at a dose 300ppm × 6hr/day ×
5 days/week for 2 weeks and group I was control. Group III of this experiment was treated with the leaf methanolic extract at a
dose of 100mg/kg body weight, a dose in nontoxic range. Hematological parameters (Hb%, RBC and WBC counts), cell cycle
regulatory proteins expression and DNA fragmentation analysis of bone marrow cells was performed. There was an upregulation
of p53 and p21 and downregulation of levels of CDK2, CDK4, CDK6, and cyclins D1 and E in leaf extract-treated group. DNA
w a sl e s sf r a g m e n t e di ng r o u pI I Ic o m p a r e dt og r o u pI I( P<0.05). The present study indicates that the secondary metabolites
of O. basilicum L. methanolic leaf extract, comprising essential oil monoterpene geraniol and its oxidized form citral as major
constituents, have modulatory eﬀect in cell cycle deregulation and hematological abnormalities induced by benzene in mice.
1.Introduction
Natural products have been investigated for promising new
leadsinpharmaceuticaldevelopment[1,2]aswellaspromis-
ing new source of therapeutic agents in plant secondary
metabolites that characterize certain plants or plant group
[3]. Interest in these secondary metabolites has been focused
upon their medicinal properties [4]. Monoterpenes have
long been recognized to possess signiﬁcant medicinal values
especially to cancer cells. Monoterpenes are nonnutritive
dietarycomponentsfoundintheessentialoilsofcitrusfruits,
cherry, mint, and herbs. They function physiologically as
chemoattractants or chemorepellents [5], and they are
largely responsible for the distinctive fragrance of many
plants. These 10 carbon isoprenoids are derived from the
mevalonate pathway in plants.
A number of dietary monoterpenes have antitumor
activity, exhibiting not only the ability to prevent the for-
mation or progression of cancer, but also to regress existing
malignant tumors. A variety of dietary monoterpenes have
been shown to be eﬀective in the chemoprevention and
chemotherapy of cancer [6–10]. The cancer suppressing
chemopreventive activity of monoterpenes during the pro-
motion phase of mammary and liver carcinogenesis may be
due to inhibition of tumor cell proliferation, acceleration of
the rate of tumor cell death, and/or induction of tumor cell
diﬀerentiation [11]. Now, monoterpene research is progress-
ing into human clinical trials for chemotherapeutic activity
from the last decade. Monoterpenes also possess many
characteristics of ideal chemopreventive agents, namely, eﬃ-
cacious antitumor activity, commercial availability, low cost,
oral bioavailability, and low toxicity, making it feasible to
begin considering them for human cancer chemoprevention
testing.
Ocimum basilicum L. popularly known as Tulsi in Hindi
and “Sweet Basil” in English in one of the sacred herbs for
Hindus in the Indian subcontinent. And India has one of
the oldest, richest, and most diverse cultural living traditions
associated with the use of medicinal plants [12]. The entire
plant of Ocimum basilicum L. has medicinal value although
mostly the leaves, and sometimes the seeds, are used. It has
a versatile role in traditional medicine. Earlier studies in2 Evidence-Based Complementary and Alternative Medicine
particular, the leaves of Ocimum basilicum L. oﬀer promise
to biologically active constituents such as insect repel-
lent, nematocidal, antibacterial, antifungal and antioxidants
properties [13–16]. It is also used as an antiemetic agent
[17]. In addition, more recently [18], anticancer activity of
Ocimum basilicum L. extract and its fractions was evaluated
using human cancer cell lines.
Benzene is an ubiquitous environmental chemical that
cause diﬀerent types of haematotoxicity. It is known to be
a very volatile liquid, with several organic and inorganic
constituents. These vapors constitute various components
of pollutants in the air, which are of great environmental
and humanhealth concern.Exposures tothese pollutants are
common in the reﬁneries, oil ﬁelds, refueling stations, petro-
chemical industries, and motor mechanical workshops. A
good percent of human populace is directly or indirectly
exposed to these pollutants in the course of their day-to-day
activities. Generally, those occupationally exposed constitute
the population at greater risk of frequent exposure [19, 20].
The potential health hazards associated with chronic or
subchronic exposure to these ubiquitous pollutants in the
environment has attracted the attention of the general public
and scientiﬁc community in particular.
Exposure of mice to benzene vapour induces inﬂam-
matory responses, oxidative stress, alterations in cell cycle
progression and DNA damage, and so forth, which together
have been implicated in various blood diseases, including
the development of acute myeloid leukemia [21, 22]. In
this regard, the benzene-exposed animal model can act as a
signiﬁcant template for the study of environmental-occupa-
tionalcancerswithrespecttodiﬀerentparametersmeasuring
clinical prevention intervention. The present study was
designed to determine whether oral application of the
methanolic leaf extracts Ocimum basilicum L. had any role in
prevention of benzene-induced alterations in cell cycle
progression in mouse bone marrow.
2.MaterialsandMethods
2.1. Plant Material Collection. Fresh leaves of Ocimum basili-
cumL.werecollectedfrommedicinalandaromaticplantgar-
den, Department of Botany, University of Kalyani, Kalyani,
India, in August of 2011, which is located at 22◦57 N
latitude,88◦22 Elongitudewithanaveragealtitudeof9.75m
above mean sea level. The taxonomic identiﬁcation of plant
material was conﬁrmed by Dr. G. G. Maity, Professor of
Taxonomy, Taxonomy and Plant systematic Unit, Depart-
ment of Botany, University of Kalyani. The voucher spec-
imens (PDG/Bot. 136) was deposited and preserved in the
Department of Botany, University of Kalyani, Kalyani, India,
for reference.
2.2. Other Materials. The primary antibodies speciﬁc for
cyclin D1, cyclin E, CDK2, CDK4, CDK6, Cip1/p21, p53 and
β-actin and the secondary antibodies were purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). All
other chemicals used in our experiments were of analytical
grade. Blood collected from subacute treatment group was
usedfortheestimationofserumbiochemicalparameterslike
serum glutamate oxaloacetate transaminase (SGOT), serum
glutamate pyruvate transaminase (SGPT), serum alkaline
phosphatase (ALP), serum total cholesterol, total protein,
urea, uric acid, and creatinine contents by using reagent kits
(Span Diagnostics, Surat, India), following the instructions
of manufacturer.
2.3.ExperimentalAnimals. Six-toeight-week-oldSwissalbi-
nomalemice(Mus musculus)werepurchasedfromareputed
supplier at a regular basis from maintained strain and were
housed in a stainless steel wire cages (Tarsons, India) and
maintained on a 12-hour light-dark cycle. Pellet diet (West
Bengal Diary and Poultry Development Corp. Ltd., Kalyani
Industrial Area, Kalyani) was provided ad libitum except
during the 6-hour daily period of benzene inhalation. Water
was supplied ad libitum automatically through the tubing
throughout the study.
Benzene (MERCK, India) vapour was generated by heat-
ingliquidbenzeneto16◦Candchanneledintotheinhalation
chamber. The groups of experimental mice were exposed
300ppm, benzene for 6hr/day, 5 days/week for 2 weeks in
1.3m3 inhalation chambers (S.B. Equipments, WB, India)
and one control group was exposed to ambient air for the
same time duration, interval, and periods. Benzene concen-
trationinthechamberswasmonitoredathalf-hour.intervals
duringdailyexposures.Thetemperatureandhumidityinthe
chambers were automatically maintained at 24 ± 1◦Ca n d
55 ± 10%, respectively. This animal can act as a model for
benzene-exposed haematotoxicity and leukemogenesis lead-
ing to secondary acute myelocytic leukemia (unpublished
data).
2.4. Preparation of Plant Extract. Secondary metabolites,
including ﬂavonoids and other phenolic compounds, were
extracted from dry leaves of Ocimum basilicum L. Collected
plant material was dried in shade and ground in a grinder
with a 2mm diameter mesh. The dried and powdered plant
materials (100gm) were extracted successively using with
500ml of methanol (1:5w/v) by using Soxhlet extractor for
24 hours at a temperature not exceeding the boiling point of
the solvent [23] .T h ee x t r a c t sw e r eﬁ l t e r e du s i n gW h a t m a n
ﬁlter paper (Number 1) and then concentrated in vacuo at
40◦C using a Rotary evaporator. The residues obtained were
stored in dark glass bottles at −20◦C in air tight containers
for further tests. The yield of the oils was calculated based on
dried weight of plant materials.
2.5. GC-MS and GC-FID Analysis. GC-MS analyses of the
essential oils were performed on a Hewlett-Packard gas chro-
matograph, model 6890, equipped with a FID, using HP-
5MScapillarycolumn(30mlength ×0.25mmi.d ×0.25μm
ﬁlm thickness), Agilent Technologies, USA. The injector was
s e ta t2 5 0 ◦C and the detector at 280◦C, respectively. Oven
temperature of the chromatogram was raised from 60◦Ct o
280◦C, respectively, at the heating rate of 10◦C/min then
isothermally held for 5min. The injector volume was 1.0μL.
The solvent delay was 2min and injected in a split ratio of
1:10. Helium was used as carrier at 15P.S.I. inlet pressure.
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of their GC retention indices (RI) and mass spectra with
those of the authentic standard compounds. Quantiﬁcation
of the relative amount of the individual components was
performed according to the area percentage method.
2.6. Subacute Toxicity Study of the Plant Extract. The crude
methanolicleafextractswereevaluatedfortheirtoxicityinO.
basilicum L. noninfected male Swiss albino mice aged six to
eight weeks and weighing 22–28g. For the test of toxicity of
theextract,30micewererandomly divided intothreegroups
of ten animals (5 males and 5 females) per cage. Before oral
administration of a dose, the mice were fasted for one to two
hrs [24]. Then the extract was dissolved in distilled water
and administered daily by oral gavage to the mice, groups II
and III and the control group (group I) receiving respective
volume of distilled water (vehicle), for 29 days. The mice in
group II were given orally the extract of O. basilicum L. at a
dose of 50mg/kg, and the mice in group III were given the
extract at dose of 1500mg/kg of body weight. Then, the mice
were observed continuously for one hr after the treatment;
intermittently for four hrs, and thereafter over a period of 29
days. The mice were observed for gross behavioral changes,
coat conditions, discharge, movement, body weight changes,
serum biochemical parameters, hematological parameters,
and mortality for 30 days to test subacute toxicity.
2.7.HematologicalParameters. Aftercompletionofthetreat-
ment with plant extract, the animals were made to fast
overnight and sacriﬁced on the 30th day by decapitation
and blood was collected. Blood hemoglobin concentration
(g%) was determined using Sahli’s hemoglobinometer and
total WBC and RBC were counted using Neubauer’s hemo-
cytometer [25]. Other blood parameters including platelet
count, diﬀerential count of monocyte, lymphocyte, neu-
trophil and diﬀerentials of RBC such as hematocrit, MCV,
M C H ,a n dM C H Cw e r ep e r f o r m e d .
2.8. Bone Marrow Sampling. The femur bone of the sacri-
ﬁced experimental mice was dissected and both the proximal
and distal ends were removed. Phosphate buﬀer solution of
pH 7.2 was injected gently into one end of the shaft. This
process was followed to ﬂush out the bone marrow through
the opposite end into a collection vessel to prepare single cell
suspension within one hour of stopping benzene inhalation.
2.9. Immunoblotting. Protein extracts of the bone marrow
were prepared using 5 diﬀerent animals individually by
sonicating femoral bone marrow cells in a cell lysis buﬀer
containing 20% SDS, 2mM phenylmethyl sulphonyl ﬂu-
oride, and a protease inhibitor/phosphate inhibitor [26].
ProteinconcentrationwasquantiﬁedusingBradfordmethod
[27]. Protein extracts from bone marrow (15μg for p21 and
10μg for other) were denatured, subjected to 12% (W/V)
SDS-PAGE, and then transferred to PVDF membranes. After
blocking nonspeciﬁc binding sites by incubating the mem-
branes with 5% nonfat dried milk and 0.1% Tween 20 in
Tris buﬀered saline (TTBS, pH 7.4) for 1 hour at room
temperature, the membranes were incubated overnight at
4◦C in the presence of diluted primary antibodies. The
Table 1: Treatment schedule.
Groups Treatment
I Not received any treatment
II Benzene exposed, received only vehicle, distilled water
containing 10% DMSO
III
Benzene exposed, received plant extract suspended in
distilled water containing 10% DMSO at a dose of
100mg/kg body weight for 4weeks
membranes were then washed with TTBS and incubated
with 1:2000 horseradish-peroxidase conjugated secondary
antibodies for 50 minutes at room temperature. To visualize
the bands, the membranes were treated with a detection
reagent for 1 minute. Band densities were measured using an
image analyzer (image J, NIH).
2.10. DNA Fragmentation Assay. DNA was extracted from
bone marrow single cell preparation (as mentioned before)
using reagents and protocol suggested by Bangalore Genei
(PI.NO:KT23).DNAconcentrationwasmeasuredat260nm
usingaspectrophotometer(Varian,Germany).DNAextracts
were then subjected to 0.8% agarose gel electrophoresis
using 1X TAE buﬀer as running buﬀer (composition: 40mM
Tris-acetate, 1mM EDTA) and ethidium bromide (ﬁnal
concentration into gel 0.5μg/mL) as staining agent. 5μLo f
100bp DNA ladder was loaded into one well in each assay.
Finally, the gel was visualized and photographed using a gel
documentation system (Genei image system).
2.11. Treatment of Benzene-Exposed Mice with Crude Meth-
anolic Leaf Extract. Since no sign of toxicity of the plant
extract was found in both low- and high-dose of plant
extract-treated group, benzene-exposed mice were treated
with the extract at a dose of 100mg/kg body weight orally
from the date of commencement of benzene exposure for 4
weeks daily. Control group of mice were treated with respec-
tive volume of distilled water containing 10% DMSO
following the same schedule. During treatment, mice were
supplied pelleted feed and water ad libitum (Table 1).
2.12. Ethical Clearance. The protocol used in this study was
approved by the animal ethical committee, Department of
Zoology, University of Kalyani (under Committee for the
Purpose of Control and Supervision of Experiments on
Animals, India).
2.13. Statistical Analysis. The two-tailed Students t-test
was done to determine signiﬁcance of diﬀerences between
benzene-exposed and plant leaf extract-treated group to
control group. Diﬀerences considered as signiﬁcance at P<
0.05 level.
3. Results and Discussion
3.1.EssentialOilProﬁlesofO.basilicumL.Leaves. Thesimple
quantitative analysis of the crude methanolic extract showed
remarkablevariationsinessentialoilcompositionofO. basil-
icum L. from West Bengal. The yield of the essential oils4 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Chromatograms GC analysis of essential oils from Ocimum basilicum L.
Table 2: Percentage composition of the essential oils of Oci-
mumbasilicum L. cultivated in West Bengal.
Compound
aRetention indices
(RI) in min.
bEssential oil (%)
α-Pinene 4.76 0.23
Camphor 4.87 0.64
Citral 5.26 23.51
Geraniol 5.76 34.89
Cineole 5.83 0.05
β-Pinene 5.92 0.19
Citronellal 5.96 0.59
Eugenol 6.57 1.33
Vanillin 6.72 0.27
Linalool 7.41 2.21
Methanol — —
aIdentiﬁcation of oil components was based on their relative retention
indices (retention times) with those of authentic standards.
bQuantitative estimation was done by analysis of FID area percent data.
obtained from dry leaf of O. basilicum L. was 1.77% (w/v)
and the dominant or major constituents in sample were
geraniol and citral ranging between 34.89% and 23.51% of
the total oils (Table 2, Figure 1). Although methyl chavicol,
linalool, methyl cinnamate, methyleugenol, eugenol, and
geraniol are reported as major components of the oils
of diﬀerent chemotypes of O. basilicum L. [28–30]. The
variation in the oil composition could be attributed to dif-
ferences in soil conditions and altitude. It was observed that
linalool and geraniol are the main components in Ocimum
basilicum L. from Bangladesh, and the authors concluded
that the oil composition could be dependent on climatic
conditions [31]. In the present study, our results showed that
geraniol and citral and the main constituents of O. basilicum
L. in respect of West Bengal are condition. The observed
variationsmaybeduetodiﬀerentenvironmentalandgenetic
factorsandthenutritionalstatusoftheplantsaswellasother
factors that can inﬂuence the oil composition.
3.2. Evaluation of Nontoxicity of Plant Extract. Physicochem-
ical observations were recorded to determine potential toxic
eﬀects of infused plant material in the animals. No adverse
eﬀectsuchasbehavioralchanges,coatconditionsalterations,
discharge and movement abnormality was seen for both
group II and group III animals. No mice were found to be
died during the study and nonsigniﬁcant changes of body
weight, serum biochemical parameters, and hematological
parameters (Table 3) were due to normal growth of the
animals. So, the selected dose of plant extract is nontoxic.
3.3. Plant Material Arrest Benzene-Induced Cell Cycle Deregu-
lation. Reduced expression of cell cycle regulatory proteins
such as p53 and p21 has been implicated in benzene-
induced hematotoxicity in mice [26]. Based on our results,
we hypothesized that the plant extract might have modu-
latory eﬀects on cell cycle regulatory proteins. As shown in
Figure 2, it is evident that the expression levels of cyclins
(cyclins D1, E), CDK2, CDK4, and CDK6 were considerably
higher in benzene-induced mice compared with control
mice. However, treatment of mice with the material after
benzene exposure resulted in inhibition of benzene-induced
expressionlevelsofcyclins(cyclinsD1,E),CDK2, CDK4and
CDK6 compared with proteins obtained from nontreated
mice. The level of Cip1/p21, which is a universal inhibitor
of cell cycle progression, is transcriptionally activated by p53
after benzene exposure [26, 32]. Treatment of plant material
resulted in the enhancement of the levels of p21 and p53 inEvidence-Based Complementary and Alternative Medicine 5
Table 3: Evaluation of nontoxicity of the plant material. Eﬀect of leaf methanolic extract on serum biochemical, hematological parameters,
and body weight after subacute administration. Data are represented as mean±SEM.
Parameters Control Lower dose (50mg/Kg body weight) Higher dose (1500mg/Kg body weight)
(group I) (group II) (group III)
SGOT (IU/dL) 40.75±1.12 41.08±1.19 40.96±1.15
SGPT (IU/ dL) 34.22±1.19 34.98±1.16 35.11±1.13
ALP (IU/dL) 81.12±1.78 80.56±1.76 80.01±1.72
Bilirubin (mg/dL) 0.86±0.13 0.85±0.11 0.86±0.12
Cholesterol (mg/dL) 149.25±9.3 150.33±8.7 150.69±8.9
Total protein (mg/dL) 6.90±2.09 6.89±2.01 6.98±2.33
Urea (mg/dL) 41.64±1.32 42.09±1.21 42.67±1.31
Uric acid (mg/dL) 5.48±1.77 5.12±1.56 5.19±1.67
Creatinine (mg/mL) 0.93±0.12 0.91±0.21 0.92±0.18
RBC (× 1012/L) 6.6±0.12 6.6±0.16 6.7±0.13
Hb (g/dL) 13.2±0.22 13.1±0.28 12.9±0.31
WBC (× 109/L) 31.3±0.42 31.2±0.0.38 32.1±0.26
Platelet (× 109/L) 756±41.2 736±46.1 750±42.4
Body weight (g) 23±1.2 23±1.5 23±1.4
Control BE
Treated
CDK2
Cyclin E
CDK4
CDK6
Cyclin D1
β-actin
with PE
P53
P21
Figure 2: Immunoblotting of p53, p21, CDK2, cyclin E, CDK4,
CDK6, cyclin D1. Panel 1: proteins from control animal; panel
2: proteins from benzene exposed animal; panel 3: proteins from
animal treated with plant extract.
benzene-exposed mice compared with nontreated benzene
exposed mice.
Mice exposed to benzene aﬀect cell cycle regulators in
bone marrow and blood. Regulation of cyclin-CDK com-
plexes plays a key role in cell cycle progression at diﬀerent
phases in which CDKs are negatively regulated by a group of
functionally related proteins known as CDK inhibitors, such
as Kip/Cip family members [33–35] .p 2 1i sau n i v e r s a lC D K
Table 4: Variation of blood parameters among BE (benzene
exposed) mice and treated with PE (plant extract) group. Data are
expressed as mean±SEM.
Group Hb (g%) RBC (× 1012/L) WBC (× 109/L)
Control 13.29±2.1 4.08±0.38 8.21±1.2
BE 9.96±1.3 2. 11±0.19 3.28±0.45
Treated with PE 11.96±1.22∗ 3.26±0.33∗ 4.67±0.31∗
∗Signiﬁcant increase (P<0.05) in parameters.
inhibitor and p21 inhibits DNA replication process [36, 37],
whereas p53 is upregulated in response to antiproliferative
signals.Consistentwiththesereports,methanolicleafextract
treatmentresultedinanupregulationofp53andp21andsig-
niﬁcantly reduced level of CDK4 and CDK6, cyclin D1, and
moderately reduced level of CDK2 and cyclin E in benzene-
induced animal with hematotoxicity, which may have caused
cell cycle arrest mainly in G2 phase in hematopoietic cells.
Thus, it can be suggested that modulation in cell cycle
progression and inhibition of cell proliferation could be one
of the possible mechanisms through which the leaf extract
inhibits benzene-induced cell cycle deregulation.
3.4. Hematological Parameters. The results shown in Table 4
indicate that the number of RBC, WBC, and Hb (g%) has
b e e nd e c r e a s e di nb e n z e n e - e x p o s e dg r o u pc o m p a r e dt oc o n -
trol group of animals. Hb (g%), RBC and WBC have been
decreased to 9.96 ± 1.3, 2.11 ± 0.19, and 3.28 ± 0.45, respec-
tively. After treatment of benzene-exposed mice with the
plant leaf extract the above parameters increase signiﬁcantly
(P<0.05) and the value reaches to 11.96 ±1.22, 3.26 ±0.33,
and 4.67±0.31, respectively. This result is also in accordance
with overexpression of p21 in plant extract-treated group
of animals as shown in immunoblot analysis. Among total
WBC count, lymphocyte count increases signiﬁcantly (P<
0.05) after treatment with the plant extract. Hct as RBC6 Evidence-Based Complementary and Alternative Medicine
Table 5: Variation of diﬀerential blood parameters among BE (benzene-exposed) mice and treated with PE (plant extract) group. Data are
expressed as mean±SEM.
Group Diﬀerential leukocyte count Diﬀerential of RBC Platelet count
Neutrophil (%) Monocyte (%) Lymphocyte (%) Hct (%) MCV (μm3) MCH (pg) MCHC (g/dL) (×109/L)
Control 22.03±1.98 1.92±0.06 68.34±5.12 38.09±2.11 52.78±3.46 16.22±0.12 26.44±0.35 750±38.21
BE 21.68±1.32 1.88±0.05 48.49±3.51 10.23±0.96 47.55±2.98 14.11±0.14 24.33±0.38 798±40.08
Treated with PE 21.92±1.41 1.90±0.06 62.12±4.98∗ 24.35±1.67∗ 48.34±2.76 14.56±0.13 24.49±0.36 776±39.97
∗Signiﬁcant increase (P<0.05) in parameters.
diﬀerential also increased signiﬁcantly (P<0.05) after
treatment (Table 5).
Blood parameters analysis is relevant to risk evaluation
as the hematological system has a higher predictive value
for toxicity in humans (91%) when assay involve rodents
and nonrodents [38]. Blood is an important index of phys-
iological and pathological status in man and animals and
the parameters usually measured are hemoglobin, total red
blood cell (RBC), and leukocyte (WBC) counts [39]. The
hematotoxicity of benzene is characterized by suppression
of erythromyelopoiesis, resulting in the depression of leuko-
c y t e( l y m p h o c y t ec o u n tm a i n l y )a n de r y t h r o c y t el e v e l si n
peripheral blood [32, 40]. This result is also in accordance
with overexpression of p21 as shown in immunoblot analysis
(Figure 2). But after treatment with the plant material,
decrease in blood parameters was found to be less.
3.5. DNA Fragmentation Analysis. As shown in Figure 3,
DNAfragmentationassayofbonemarrowcellscharacteristic
of apoptosis was clearly detected after benzene exposure to
miceanditisbeinglessfragmentedinmethanolicleafextract
treated group. The data were coincident with the results of
the cell cycle regulating kinases.
4. Conclusion
In conclusion, protection by plant secondary metabolites is
currently an important strategy for controlling the process of
various diseases including hematotoxicity. Therefore, there is
a need to explore medicinal plants or other natural agents
that can work as protective agents against hematotoxicity.
In the present work, our results show signiﬁcant activity
of methanolic leaf extract of Ocimum basilicum L. against
benzene-induced hematotoxicity in mice. These extract
may promote chemopreventive activity in human. On the
basis of above evidence, it is possible that monoterpenes
like geraniol, citral, and eugenol, present in the extract
may be responsible for this activity. However, this claim
demands extensive studies on synergistic pharmacodynamic
interactions of the phytochemicals as well as the eﬀects on
signal modulation which are essential for the development
of multiactive natural drugs from Ocimum basilicum L. for
cancer chemoprevention in the near future.
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